First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.

about

First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates.

Item

http://www.wikidata.org/entity/Q55454780

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@en

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@nl

type

Item

label

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@en

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@nl

prefLabel

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@en

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates.

@nl

P1476

First-Pass CYP3A-Mediated Meta ...... and Liver in Preterm Neonates

@en

P2093

Amin Rostami-Hodjegan

http://www.w3.org/2001/XMLSchema#string

Berend de Roos

http://www.w3.org/2001/XMLSchema#string

Huixin Yu

http://www.w3.org/2001/XMLSchema#string

Johannes N van den Anker

http://www.w3.org/2001/XMLSchema#string

Margreke J E Brill

http://www.w3.org/2001/XMLSchema#string

P2860

Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis

Visualization and communication of pharmacometric models with berkeley madonna

Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

Cytochrome P450 3A: ontogeny and drug disposition.

DAISY: a new software tool to test global identifiability of biological and physiological systems

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Impact of developmental pharmacology on pediatric study design: overcoming the challenges.

Anemia in children.

The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.

Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels.

P304

374-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSP4.12295

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Saskia N de Wildt

Janneke M Brussee

Catherijne A J Knibbe

Elke H J Krekels

P577

2018-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29745466

http://www.w3.org/2001/XMLSchema#string

P932

6027733

http://www.w3.org/2001/XMLSchema#string